Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect

M. M. Miller*, D. I. Hoffman, M. Creinin, J. H. Levin, R. T. Chatterton, T. Murad, R. W. Rebar

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

To determine if pregnanediol glucuronide (PG) excretion is useful in luteal phase assessment, we compared daily first morning urinary PG concentrations during the luteal phase in nine normal and nine deficient cycles. Total luteal pregnanediol excretion (44.1 ± 11.3 versus 64.0 ± 11.6 area units ± SEM) was not different. However, significantly less pregnanediol was excreted by the abnormal group during the 1st 5 days of the luteal phase (12.7 ± 1.2 versus 18.0 ± 1.7 area units ± SEM, respectively). Thus, delayed PG excretion may be characteristic of luteal phase defect and measurement of urinary PG may be useful only if daily samples during the early luteal phase are obtained.

Original languageEnglish (US)
Pages (from-to)1008-1011
Number of pages4
JournalFertility and Sterility
Volume54
Issue number6
DOIs
StatePublished - 1990

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Comparison of endometrial biopsy and urinary pregnanediol glucuronide concentration in the diagnosis of luteal phase defect'. Together they form a unique fingerprint.

Cite this